The prevalence of long COVID was high in patients living with HIV, according to a review published in eClinicalMedicine.
- Long COVID prevalence in HIV-positive individuals is estimated at 43%, with significant heterogeneity across studies.
- Antiretroviral therapy reduces poor COVID-19 outcomes, but long COVID effects in HIV patients are less understood.
- The association between HIV and long COVID remains inconclusive, with low certainty of evidence and an OR of 1.16.
- Study limitations include demographic constraints, high CD4 counts, and challenges in collecting sex and gender data.
